Table 7.
(A) | |||||||||||
In Association with Metadoxine | Without Metadoxine | ||||||||||
Age Groups
(Years) |
Period | CNS | Gastro | Resp | Nal/Flu | Others | CNS | Gastro | Resp | Nal/Flu | Others |
11–17 | 2018–2019 | 3 | 21 | 0 | 1 | 1 | 0 | 3 | 0 | 0 | 0 |
2020–2021 | 0 | 8 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |
18–24 | 2018–2019 | 6 | 48 | 7 | 7 | 1 | 4 | 3 | 5 | 0 | 0 |
2020–2021 | 1 | 8 | 3 | 4 | 2 | 2 | 3 | 0 | 0 | 2 | |
25–44 | 2018–2019 | 26 | 41 | 4 | 12 | 10 | 32 | 16 | 8 | 4 | 11 |
2020–2021 | 9 | 19 | 7 | 3 | 4 | 17 | 7 | 2 | 0 | 7 | |
45–64 | 2018–2019 | 18 | 27 | 3 | 9 | 9 | 27 | 15 | 18 | 7 | 14 |
2020–2021 | 14 | 8 | 2 | 6 | 5 | 11 | 8 | 5 | 2 | 11 | |
≥65 | 2018–2019 | 1 | 8 | 3 | 0 | 3 | 1 | 2 | 4 | 1 | 4 |
2020–2021 | 1 | 0 | 1 | 1 | 1 | 4 | 1 | 2 | 1 | 1 | |
(B) | |||||||||||
In Association with Metadoxine | Without Metadoxine | ||||||||||
Age Groups (Years) | Period | CNS | Gastro | Resp | Nal/Flu | Others | CNS | Gastro | Resp | Nal/Flu | Others |
11–17 | 2018–2019 | 1 | 18 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 |
2020–2021 | 0 | 8 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | |
18–24 | 2018–2019 | 8 | 25 | 0 | 1 | 3 | 3 | 5 | 0 | 0 | 0 |
2020–2021 | 5 | 16 | 2 | 2 | 1 | 7 | 2 | 0 | 2 | 0 | |
25–44 | 2018–2019 | 10 | 66 | 2 | 7 | 10 | 38 | 15 | 1 | 0 | 6 |
2020–2021 | 15 | 20 | 0 | 2 | 6 | 16 | 3 | 0 | 1 | 4 | |
45–64 | 2018–2019 | 18 | 49 | 1 | 5 | 13 | 30 | 19 | 6 | 0 | 14 |
2020–2021 | 11 | 27 | 2 | 7 | 10 | 12 | 10 | 7 | 0 | 10 | |
≥65 | 2018–2019 | 1 | 14 | 0 | 0 | 0 | 3 | 6 | 0 | 0 | 6 |
2020–2021 | 1 | 3 | 0 | 0 | 2 | 4 | 7 | 3 | 0 | 7 |
CNS (Central Nervous System): benzodiazepines, chlorpromazine, haloperidol and clotiapine. GI (gastrointestinal): pantoprazole, ranitidine, metoclopramide, acetylcysteine and levosulpiride. RS (Respiratory System): salbutamol, corticosteroids, theophylline, oxygen and chlorpheniramine. Nal/Flu: naloxone and/or flumazenil. Other: pain killers, antispasmodics, insulin and glucagon.